Back
  1. Home
  2. Profile of Anaëlle Duray (UMONS)
Profil

Duray Anaëlle

Main Referenced Co-authors
SAUSSEZ, Sven  (21)
Delvenne, Philippe (11)
DESCAMPS, Géraldine  (10)
Decaestecker, Christine (5)
Depuydt, Christophe (5)
Main Referenced Keywords
General Medicine (1);
Main Referenced Disciplines
Oncology (20)
Immunology & infectious disease (19)
General & internal medicine (5)
Surgery (4)
Laboratory medicine & medical technology (2)

Publications (total 21)

The most cited

96 citations (Scopus®)

Duray, A., Descamps, G., Decaestecker, C., Remmelink, M., Sirtaine, N., Lechien, J., Ernoux, P., Bletard, N., Somja, J., Depuydt, C., Delvenne, P., & Saussez, S. (24 April 2012). Human Papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope, 122 (7), 1558-1565. doi:10.1002/lary.23298 https://hdl.handle.net/20.500.12907/41101

Descamps, G., Bellier, J., Duray, A., & Saussez, S. (30 January 2016). Implications of oncogenic HPVs in alterations of the immune system in head and neck cancers [Poster presentation]. BACR Annual Meeting, ULB Erasme, Belgium.

Descamps, G., Bellier, J., Duray, A., & Saussez, S. (03 December 2015). Implications of oncogenic HPVs in alterations of the immune system in head and neck cancers [Paper presentation]. 28th Télévie's Researchers Seminar, Gembloux Agro­Bio Tech , Belgium.

Suarez-Carmona, M., Hubert, P., Gonzalez, A., Duray, A., Roncarati, P., Erpicum, C., Boniver, J., Castronovo, V., Noel, A., Saussez, S., peulen, O., Delvenne, P., & Herfs, M. (2014). ΔNp63 isoform-mediated β-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma. Oncotarget, (N° spécial).
Peer reviewed

Duray, A., Hubert, P., Delvenne, P., & Saussez, S. (05 December 2013). Analysis of immune alterations in head and neck squamous cell carcinomas associated or not with HPV [Poster presentation]. Televie's Researchers Seminar, Bruxelles, Belgium.

Duray, A., Hubert, P., Delvenne, P., & Saussez, S. (05 December 2013). Analyse des altérations immunitaires dans les cancers des voies aéro-digestives supérieures (VADS) associés ou non à HPV [Paper presentation]. Televie's Researchers Seminar, Bruxelles, Belgium.

Duray, A., Delvenne, P., & Saussez, S. (27 September 2013). Rôles des HPVs oncogènes dans la biologie des cancers des voies aéro-digestives supérieures: implications dans les altérations du système immunitaire [Paper presentation]. 6èmes Journées de l'AFIPP, France.

Duray, A., Delvenne, P., & Saussez, S. (17 May 2013). Rôles des HPVs oncogènes dans la biologie des cancers des voies aéro-digestives supérieures : implications dans les altérations du système immunitaire [Paper presentation]. Health Institute Day, Mons, Belgium.

Duray, A., Descamps, G., Decaestecker, C., Sirtaine, N., Gilles, A., Khalifé, M., Chantrain, G., Depuydt, C., Delvenne, P., & Saussez, S. (22 April 2013). Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomas. Oncology Reports, 30 (1), 371-376.
Peer Reviewed verified by ORBi

Descamps, G., Duray, A., Wattiez, R., Delvenne, P., & Saussez, S. (12 March 2013). Roles of HPV infections in head and neck squamous cell carcinomas: searching for new predictive biomarkers [Poster presentation]. 7ième Matinée des Chercheurs, Mons, Belgium.

Descamps, G., Duray, A., Wattiez, R., Delvenne, P., & Saussez, S. (29 January 2013). Roles of HPV infections in head and neck squamous cell carcinomas: searching for new predictive biomarkers [Paper presentation]. 1ère journée des doctorants en Sciences Biomédicales et Pharmaceutiques, Mons, Belgium.

Guenin, S., Mouallif, M., Hubert, P., Jacobs, N., Krusy, N., Duray, A., Ennaji, M., Saussez, S., & Delvenne, P. (2013). Interleukin-32 expression is associated with a poorer prognosis in head and neck squamous cell carcinoma. Molecular Carcinogenesis.
Peer Reviewed verified by ORBi

Descamps, G., Duray, A., Rodriguez, A., Chantrain, G., Depuydt, C., Delvenne, P., & Saussez, S. (2012). Detection and quantification of human papillomavirus in benign and malignant parotid lesions. Anticancer Research.
Peer Reviewed verified by ORBi

Duray, A., Descamps, G., Decaestecker, C., Remmelink, M., Sirtaine, N., Lechien, J., Ernoux, P., Bletard, N., Somja, J., Depuydt, C., Delvenne, P., & Saussez, S. (24 April 2012). Human Papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope, 122 (7), 1558-1565. doi:10.1002/lary.23298
Peer Reviewed verified by ORBi

Duray, A., Descamps, G., Bettonville, M., Sirtaine, N., Ernoux, P., Guenin, S., Mouallif, M., Depuydt, C., Delvenne, P., & Saussez, S. (01 August 2011). High prevalence of high-risk human papillomavirus in palatine tonsils from healthy children and adults. Otolaryngology - Head and Neck Surgery, 145 (2), 230-235.
Peer Reviewed verified by ORBi

Duray, A., Descamps, G., Arafa, M., Decaestecker, C., Remmelink, M., Sirtaine, N., Ernoux, P., Mutijima, E., Somja, J., Depuydt, C., Delvenne, P., & Saussez, S. (01 July 2011). High incidence of high-risk HPV in benign and malignant lesions of the larynx. International Journal of Oncology, 39 (1), 51-59.
Peer Reviewed verified by ORBi

Bruyère, C., Lonez, C., Duray, A., Cludts, S., Ruysschaert, J.-M., Saussez, S., Yeaton, P., Kiss, R., & Mijatovic, T. (01 May 2011). Considering temozolomide as a novel potential treatment for esophageal cancer. Cancer, 117 (9), 2004-2016.
Peer Reviewed verified by ORBi

Remmelink, M., de LEVAL, L., Decaestecker, C., Duray, A., Crompot, E., Sirtaine, N., André, S., Kaltner, H., Leroy, X., Gabius, H.-J., & Saussez, S. (01 March 2011). Quantitative immunohistochemical fingerprinting of adhesion/growth-regulatory galectins in salivary gland tumours: divergent profiles with diagnostic potential. Histopathology, 58 (4), 543-556.
Peer Reviewed verified by ORBi

Descamps, G., Duray, A., Delvenne, P., & Saussez, S. (2011). Implications of Human Papillomavirus Infections in the Biology of Head and Neck Cancers. In Human Papillomavirus and Related Diseases - From Bench to Bedside - A Clinical Perspective (pp. 221-278). INTECH.

Duray, A., Demoulin, S., Hubert, P., Delvenne, P., & Saussez, S. (27 December 2010). Immune Suppression in Head and Neck Cancers: A Review. Clinical and Developmental Immunology, 2010, 1-15.
Peer Reviewed verified by ORBi

Saussez, S., de Leval, L., Decaestecker, C., Sirtaine, N., Cludts, S., Duray, A., Chevalier, D., André, S., Gabius, H.-J., Remmelink, M., & Leroy, X. (01 May 2010). Galectin fingerprinting in Warthin's tumors: lectin-based approach to trace its origin? Histology and Histopathology, 25, 541-550.
Peer Reviewed verified by ORBi

Ernoux, P., Arafa, M., Decaestecker, C., Duray, A., Remmelink, M., Leroy, X., Herfs, M., Somja, J., Depuydt, C., Delvenne, P., & Saussez, S. (08 April 2010). Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology, 137, 173-181.
Peer Reviewed verified by ORBi

Contact ORBi UMONS